share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股sec公告 ·  06/06 10:41
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 50,000 Class A shares on 06/06/2024, with an aggregate market value of $450,000. The shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 406,319 shares were sold for gross proceeds of approximately $3.77 million.
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 50,000 Class A shares on 06/06/2024, with an aggregate market value of $450,000. The shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 406,319 shares were sold for gross proceeds of approximately $3.77 million.
Recursion Pharmaceuticals, Inc.的官員兼董事Christopher Gibson計劃於2024年06月06日出售50,000股A類股票,總市值爲$450,000。這些股票最初是在2016年09月01日獲得的創始股份,是發行人的一種補償形式。這一計劃銷售是在過去三個月的一系列交易之後進行的,共售出406,319股股票,總收益約爲$3.77百萬美元。
Recursion Pharmaceuticals, Inc.的官員兼董事Christopher Gibson計劃於2024年06月06日出售50,000股A類股票,總市值爲$450,000。這些股票最初是在2016年09月01日獲得的創始股份,是發行人的一種補償形式。這一計劃銷售是在過去三個月的一系列交易之後進行的,共售出406,319股股票,總收益約爲$3.77百萬美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息